133 related articles for article (PubMed ID: 31904058)
1. Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy.
Rao SS; Lago L; Gonzalez de Vega R; Bray L; Hare DJ; Clases D; Doble PA; Adlard PA
Metallomics; 2020 Feb; 12(2):301-313. PubMed ID: 31904058
[TBL] [Abstract][Full Text] [Related]
2. Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy.
Solovyev N; El-Khatib AH; Costas-Rodríguez M; Schwab K; Griffin E; Raab A; Platt B; Theuring F; Vogl J; Vanhaecke F
J Biol Chem; 2021; 296():100292. PubMed ID: 33453282
[TBL] [Abstract][Full Text] [Related]
3. Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.
Rao SS; Lago L; Volitakis I; Shukla JJ; McColl G; Finkelstein DI; Adlard PA
Neurotherapeutics; 2021 Apr; 18(2):1081-1094. PubMed ID: 33410108
[TBL] [Abstract][Full Text] [Related]
4. The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy.
Rao SS; Portbury SD; Lago L; Bush AI; Adlard PA
J Alzheimers Dis; 2020; 77(2):753-771. PubMed ID: 32741833
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the spatial distribution of metals and profile of metalloprotein complexes in a mouse model of repetitive mild traumatic brain injury.
Juan SMA; Daglas M; Gunn AP; Lago L; Adlard PA
Metallomics; 2022 Dec; 14(12):. PubMed ID: 36460052
[TBL] [Abstract][Full Text] [Related]
6. Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry.
Hare DJ; Grubman A; Ryan TM; Lothian A; Liddell JR; Grimm R; Matsuda T; Doble PA; Cherny RA; Bush AI; White AR; Masters CL; Roberts BR
Metallomics; 2013 Dec; 5(12):1656-62. PubMed ID: 24132241
[TBL] [Abstract][Full Text] [Related]
7. Choice of mobile phase: Implications for size exclusion chromatography-inductively coupled plasma-mass spectrometry analyses of copper, zinc and iron metalloproteins.
Lago L; Thomas ORB; Roberts BR
J Chromatogr A; 2020 Apr; 1616():460806. PubMed ID: 31916987
[TBL] [Abstract][Full Text] [Related]
8. Age modulates the injury-induced metallomic profile in the brain.
Portbury SD; Hare DJ; Sgambelloni CJ; Bishop DP; Finkelstein DI; Doble PA; Adlard PA
Metallomics; 2017 Apr; 9(4):402-410. PubMed ID: 28170006
[TBL] [Abstract][Full Text] [Related]
9. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
10. Zinc Transporter-3 Knockout Mice Demonstrate Age-Dependent Alterations in the Metalloproteome.
Hancock SM; Portbury SD; Gunn AP; Roberts BR; Bush AI; Adlard PA
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012946
[TBL] [Abstract][Full Text] [Related]
11. A novel absolute quantitative imaging strategy of iron, copper and zinc in brain tissues by Isotope Dilution Laser Ablation ICP-MS.
Feng L; Wang J; Li H; Luo X; Li J
Anal Chim Acta; 2017 Sep; 984():66-75. PubMed ID: 28843570
[TBL] [Abstract][Full Text] [Related]
12. TBK1 interacts with tau and enhances neurodegeneration in tauopathy.
Abreha MH; Ojelade S; Dammer EB; McEachin ZT; Duong DM; Gearing M; Bassell GJ; Lah JJ; Levey AI; Shulman JM; Seyfried NT
J Biol Chem; 2021; 296():100760. PubMed ID: 33965374
[TBL] [Abstract][Full Text] [Related]
13. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R
J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice.
Hastings NB; Wang X; Song L; Butts BD; Grotz D; Hargreaves R; Fred Hess J; Hong KK; Huang CR; Hyde L; Laverty M; Lee J; Levitan D; Lu SX; Maguire M; Mahadomrongkul V; McEachern EJ; Ouyang X; Rosahl TW; Selnick H; Stanton M; Terracina G; Vocadlo DJ; Wang G; Duffy JL; Parker EM; Zhang L
Mol Neurodegener; 2017 May; 12(1):39. PubMed ID: 28521765
[TBL] [Abstract][Full Text] [Related]
15. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
Javidnia M; Hebron ML; Xin Y; Kinney NG; Moussa CE
J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476
[TBL] [Abstract][Full Text] [Related]
16. TOC1: a valuable tool in assessing disease progression in the rTg4510 mouse model of tauopathy.
Ward SM; Himmelstein DS; Ren Y; Fu Y; Yu XW; Roberts K; Binder LI; Sahara N
Neurobiol Dis; 2014 Jul; 67():37-48. PubMed ID: 24631720
[TBL] [Abstract][Full Text] [Related]
17. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.
Matsumoto G; Matsumoto K; Kimura T; Suhara T; Higuchi M; Sahara N; Mori N
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772786
[TBL] [Abstract][Full Text] [Related]
18. Characterising the brain metalloproteome in Down syndrome patients with concomitant Alzheimer's pathology.
Malakooti N; Roberts B; Pritchard MA; Volitakis I; Kim RC; Lott IT; McLean CA; Finkelstein DI; Adlard PA
Metallomics; 2020 Jan; 12(1):114-132. PubMed ID: 31764918
[TBL] [Abstract][Full Text] [Related]
19. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
20. Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.
Vega IE; Umstead A; Wygant CM; Beck JS; Counts SE
Curr Alzheimer Res; 2018; 15(12):1086-1095. PubMed ID: 30101710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
